                         SEQUENCE LISTING

<110>  MEMORYPLUS LTD.
       KNAFO, Shira
 
<120>  COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING A NEUROLOGICAL 
       CONDITION

<130>  P-586107-PC

<150>  US 62/824,334
<151>  2019-03-27

<160>  27    

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  1

Gln His Thr Gln Ile Thr Lys Val 
1               5               


<210>  2
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Gln His Ser Gln Ile Thr Lys Val 
1               5               


<210>  3
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X denotes Ser or Thr

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X denotes Ser or Thr

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X denotes Val, Leu or Ile

<400>  3

Gln His Xaa Gln Ile Xaa Lys Xaa 
1               5               


<210>  4
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Pro Phe Asp Glu Asp Gln His Thr Gln Ile Thr Lys Val 
1               5                   10              


<210>  5
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  5

Phe Asp Glu Asp Gln His Thr Gln Ile Thr Lys Val 
1               5                   10          


<210>  6
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  6

Asp Glu Asp Gln His Thr Gln Ile Thr Lys Val 
1               5                   10      


<210>  7
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  7

Glu Asp Gln His Thr Gln Ile Thr Lys Val 
1               5                   10  


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  8

Asp Gln His Thr Gln Ile Thr Lys Val 
1               5                   


<210>  9
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Gln His Thr Gln Ile Thr Lys Leu 
1               5               


<210>  10
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  10

Gln His Thr Gln Ile Thr Lys Ile 
1               5               


<210>  11
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  11

Gln His Thr Gln Ile Ser Lys Val 
1               5               


<210>  12
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  12

Gln His Thr Gln Ile Ser Lys Leu 
1               5               


<210>  13
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  13

Gln His Thr Gln Ile Ser Lys Ile 
1               5               


<210>  14
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  14

Pro Phe Asp Glu Asp Gln His Ser Gln Ile Thr Lys Val 
1               5                   10              


<210>  15
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  15

Phe Asp Glu Asp Gln His Ser Gln Ile Thr Lys Val 
1               5                   10          


<210>  16
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  16

Asp Glu Asp Gln His Ser Gln Ile Thr Lys Val 
1               5                   10      


<210>  17
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  17

Glu Asp Gln His Ser Gln Ile Thr Lys Val 
1               5                   10  


<210>  18
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  18

Asp Gln His Ser Gln Ile Thr Lys Val 
1               5                   


<210>  19
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  19

Gln His Ser Gln Ile Thr Lys Leu 
1               5               


<210>  20
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  20

Gln His Ser Gln Ile Thr Lys Ile 
1               5               


<210>  21
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  21

Gln His Ser Gln Ile Ser Lys Val 
1               5               


<210>  22
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  22

Gln His Ser Gln Ile Ser Lys Leu 
1               5               


<210>  23
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  23

Gln His Ser Gln Ile Ser Lys Ile 
1               5               


<210>  24
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  24
caggtggtgg agcaagatg                                                    19


<210>  25
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  25
ccgagatctc tgaagtgaag atggatg                                           27


<210>  26
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  26
cctctttgtg actatgtgga ctgatgtcgg                                        30


<210>  27
<211>  28
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  27
gtggataccc cctcccccag cctagacc                                          28


